(Q44177449)

30 November 2017

title

Persistence of earlier HIV-1 drug resistance mutations at new treatment failure (English)

1 reference

30 November 2017

Veronica Svedhem

1

1 reference

30 November 2017

Annica Lindkvist

series ordinal

2

1 reference

30 November 2017

Knut Lidman

series ordinal

3

1 reference

30 November 2017

Anders Sönnerborg

series ordinal

4

1 reference

30 November 2017

publication date

1 December 2002

1 reference

Journal of Medical Virology

30 November 2017

published in

1 reference

30 November 2017

volume

68

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

473-478

1 reference

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome

30 November 2017

cites work

1 reference

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

21 January 2018

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

Recent origin of human immunodeficiency virus type 1 variants in resting CD4+ T lymphocytes in untreated and suboptimally treated subjects

21 January 2018

1 reference

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to a stavudine-containing regimen

21 January 2018

1 reference

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy

21 January 2018

1 reference

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

21 January 2018

1 reference

Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy

21 January 2018

1 reference

Hidden dangers of incompletely suppressive antiretroviral therapy

21 January 2018

1 reference

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy

21 January 2018

1 reference

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.10246

1 reference

30 November 2017

1 reference